Last reviewed · How we verify

NCT07306689

Posttraumatic Stress Disorder in Ectopic Pregnancy

Recruiting now Last updated 29 December 2025
What this trial tests

trial testing Impact of Event Scale - Revised (IES-R) questionnaire in Ectopic Pregnancy in 200 participants. Currently enrolling.

Timeline
15 December 2025
Primary endpoint
31 December 2027
31 December 2027

Quick facts

Lead sponsorJagiellonian University
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment200
Start date15 December 2025
Primary completion31 December 2027
Estimated completion31 December 2027
Sites2 locations across Poland

Drugs / interventions tested

Conditions studied

Sponsor

Jagiellonian University

Who can join

Adults 18 to 45, female only, with Ectopic Pregnancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of the study is to prospectively assess the prevalence of post-traumatic stress disorder (PTSD) symptoms in a population of women who have experienced a diagnosis of ectopic pregnancy. The investigation into the prevalence of PTSD symptoms will aid in better identifying women who may benefit from early psychological intervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Impact of Event Scale - Revised (IES-R) questionnaire

Trials testing the same drug.

Other recruiting trials for Ectopic Pregnancy

Currently open trials in the same condition.

Other Jagiellonian University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07306689.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing